Skip to main content
OpenTrials

Clinical trial condition

Dyslipidemias

Explore clinical trials studying Dyslipidemias. Study availability and eligibility vary by location and protocol.

1,809 public trials 143 recruiting studies
Refine in advanced search Browse all conditions

Dyslipidemias trial results

Active, Not Recruiting

CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)

NCT05681351

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • LA Universal Research Center, Inc. Los Angeles, California, United States
  • University of California, San Diego (UCSD) San Diego, California, United States
  • Metabolic Institute of America Tarzana, California, United States
  • Excel Medical Clinical Trials Boca Raton, Florida, United States
View all 262 locations
View Trial Details
Active, Not Recruiting

VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease

NCT06249165

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +9 more
Locations
  • Univ. of Alabama - Birmingham Birmingham, Alabama, United States
  • Univ. of California - Irvine Orange, California, United States
  • San Francisco General Hospital San Francisco, California, United States
  • Emory University Atlanta, Georgia, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Study of Plozasiran in Adults With Severe Hypertriglyceridemia

NCT06347016

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • Research Site 1 Birmingham, Alabama, United States
  • Research Site 2 Mobile, Alabama, United States
  • Research Site 3 Beverly Hills, California, United States
  • Research Site 4 Canoga Park, California, United States
View all 149 locations
View Trial Details
Active, Not Recruiting

Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension

NCT06492291

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations
  • Alliance for Multispecialty Research, LLC ( Site 0027) Daphne, Alabama, United States
  • G&L Research ( Site 0035) Foley, Alabama, United States
  • Synexus Clinical Research US, Inc.-Synexus Clinical Research US, Inc - Central Phoenix ( Site 0048) Phoenix, Arizona, United States
  • National Heart Institute-Research ( Site 0029) Beverly Hills, California, United States
View all 222 locations
View Trial Details
Active, Not Recruiting

An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

NCT05900141

Conditions
Cardiovascular Diseases, Dyslipidemias, Hyperlipidemias, +5 more
Locations
  • Novartis Investigative Site Frankfurt am Main, Hesse, Germany
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Cloppenburg, Germany
  • Novartis Investigative Site Dresden, Germany
View Trial Details

Related conditions